Recent studies have shown that VEGF-A may be well-regulated by miR-126 in normal tissues and miR-126 was restrictly expressed in human breast cancer where the VEGF/PI3K/AKT signaling pathway was vigorously activated. The gene discussed is VEGFA; the disease is breast carcinoma.